WHO criticizes Indian supplier of tuberculosis drugs
09/09/2015 // JusticeNewsFlash // (press release)
London – The World Health Organization has criticized a major India based supplier of tuberculosis drugs over the company’s processes for testing and manufacturing. Reuters reported that the warning letter issued to Mumbai-based Svizera Labs, which is part of Maneesh Pharmaceuticals, says that the United Nations agency would suspend the products’ approval and use if “critical and major observations are not corrected within a reasonable time frame.”
Svizera is one of four major contracted suppliers of medicines for the Stop TB Partnership, which is an organization backed by the WHO that was started in 2001 to help battle tuberculosis in over 100 countries.
The WHO sent the “notice of concern” on September 2, outlining 10 issues concerning the company.
Svizera Managing Director Vinay Sapte has reportedly said he disagreed with the report’s content, and that the factory had been found to be up to standard since the WHO inspected it in June, saying in an emailed statement, “We are convinced that … we can resolve this issue in short time.”
More stories related to The World Health Organization /?s=The+World+Health+Organization
Source: Reuters News Story Link: http://news.yahoo.com/sounds-alarm-over-big-indian-supplier-tuberculosis-drugs-134719834–finance.html;_ylt=AwrBT9quaOpVBy4ApadXNyoA;_ylu=X3oDMTByMjB0aG5zBGNvbG8DYmYxBHBvcwMxBHZ0aWQDBHNlYwNzYw–